Customized Weight loss Plan just for You!

---

Semaglutide is an effective means of stabilizing glycemic levels. The drug works by boosting insulin secretion and reducing glucagon secretion, which ultimately achieves blood sugar stabilization. Semaglutide has proven to be an effective means of reducing appetite, curbing food cravings, and attaining glycemic balance. The effects of Semaglutide are most effective when combined with a healthy diet and exercise routine.

Compounded Semaglutide:

• Mechanism of Action: Semaglutide mimics the GLP-1 hormone, enhancing insulin secretion in response to high blood sugar levels. It also slows gastric emptying and reduces appetite.
• Primary Benefits: Improved blood sugar control, significant weight loss, and reduced risk of cardiovascular events.Semaglutide is treatment that helps patients address weight loss by suppressing appetites. When combined with a healthy lifestyle and regular exercise, Semaglutide has proven to be effective. 

Not all patients are considered eligible for treatment. Semaglutide candidates will have a BMI >25. Disqualifing factors include diagnosis of Diabetes,  history of Pancreatitis, history of gastroparsis, history of kidney disease or Acute kidney injury. 

During you consultation, your medical history will be thoroughly reviewed to ensure that treatment with Semaglutide is safe. Patients with a history of tumors and/or cancer may not be eligible for treatment. The practitioner must be made aware of any medications and/or supplements that the patient is currently taking.

Tirzepatide is an effective means of stabilizing glycemic levels. The drug works by boosting insulin secretion and reducing glucagon secretion, which ultimately achieves blood sugar stabilization. Tirzepatide has proven to be an effective means of reducing appetite, curbing food cravings, and attaining glycemic balance. The effects of Tirzepatide are most effective when combined with a healthy diet and exercise routine.

Compounded Tirzepatide:

• Mechanism of Action: Tirzepatide is a dual agonist that mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying.
• Primary Benefits: Superior blood sugar control, more substantial weight loss compared to GLP-1 agonists alone, and improved insulin sensitivity.

Not all patients are considered eligible for treatment. Tirzepatide candidates will have a BMI >25. Disqualifing factors include diagnosis of Diabetes,  history of Pancreatitis, history of gastroparsis, history of kidney disease or Acute kidney injury. 

During you consultation, your medical history will be thoroughly reviewed to ensure that treatment with Tirzepatide is safe. Patients with a history of tumors and/or cancer may not be eligible for treatment. The practitioner must be made aware of any medications and/or supplements that the patient is currently taking.